TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05470439

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: My Interprofessional Care team for Adherence and Research Engagement (MI-CARE)
Description: MI-CARE is an innovative, tailored coordinated care intervention by pharmacist-community health worker (CHW) team derived from a previous research and a clinical pilot implementation. MI-CARE will identify and address individual, clinical, social-cultural and structural barriers to medication adherence and hypertension management. MI-CARE consists of an initial individualized needs assessment (Baseline). During Months 1-2, pharmacist-CHW team will deliver a tailored intervention including an individualized medication chart, preferred adherence aids, hypertension therapy optimization, tailored education based on medication beliefs, tools to combat social stressors, and referrals for structural barriers such as food insecurity, transportation and drug costs. Tailored family/care partner participation and telehealth visits will be provided when needed during this time. A booster visit to assess patient progress and reinforce intervention components will occur at Month 2.
Study: NCT06168526

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acute physical activity
Description: Regarding the first aim, participants will go through five different conditions using a within-participants cross-over design in a randomized order: control group (quietly sitting), light intensity (40% VO2max), moderate intensity (63% VO2max), or vigorous intensity (100% VO2max) exercise. All conditions will last 16 minutes and 15 seconds. The exercise conditions will be organized following an interval protocol, which includes 22 bouts of 30 seconds running at the established intensity with 15 seconds of passive rest between bouts. In addition, to achieve the second aim, the active break will be designed taking into account the intensity of physical activity that proves to have the greatest benefits on cognition and well-being.
Study: NCT04505020

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D Print + Conventional imaging
Description: This group will have a 3D reconstruction of their hip printed using a 3D printer so that the PI can use it in their pre and intra-operative planning along with traditional imaging.

Intervention type: OTHER
Group type: OTHER
Intervention: Conventional imaging
Description: This group will have CT, MRI and X-Ray imaging completed so that the PI can use it in their pre and intra-operative planning.
Study: NCT04431362

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-selected music
Description: Participants will be given iPods and headphones to listen to their music
Study: NCT04099862

Intervention type: PROCEDURE
Intervention: ERCP
Description: Endoscopic retrograde cholangiopancreatography (ERCP)

Intervention type: PROCEDURE
Intervention: EUS-BD
Description: Endoscopic UltraSound Biliary Drainage
Study: NCT06091553

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine alone
Description: 30 mg once daily for 1 week, then 60 mg once daily
Study: NCT05748067

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SDF
Description: Silver diamine fluoride

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SDF
Description: Silver diamine fluoride

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: HVGIC restoration
Description: High viscosity glass ionomer restoration
Study: NCT06443216

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Auditory closed-loop stimulation
Description: Auditory closed-loop suppression of slow wave sleep

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Auditory closed-loop stimulation
Description: Auditory closed-loop suppression of slow wave sleep

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham stimulation
Description: No auditory stimulation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham stimulation
Description: No auditory stimulation
Study: NCT06091553

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine augmented with gabapentin
Description: 30 mg once daily for 1 week, then 60 mg once daily 300 mg at bedtime

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine augmented with amitriptyline (as combined therapy)
Description: 10 to 25 mg once daily at bedtime 30 mg once daily for 1 week, then 60 mg once daily
Study: NCT05984134

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NL005 Middle Dose
Description: Patients in this treatment group will receive NL005 for 0.5 ug/kg respective.Continuous administration for 7 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NL005 High Dose
Description: Patients in this treatment group will receive NL005 for 1.5 ug/kg respective.Continuous administration for 7 days.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 30 subjects will be randomly assigned to the placebo for 7 days
Study: NCT06132022

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mandala
Description: Mandala work is one of the non-pharmacological approaches and is used to support patients and caregivers in various diseases. Mandala is a method that anyone can apply based on coloring a circular shape.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Routine care
Description: The clinic's routine information will be given to the caregivers of the control group.
Study: NCT05177198

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: M-MIST + Clindamycin augmented PRF
Description: modified minimally invasive surgical technique with Clindamycin (at concentration of 150 mg/ml) augmented platelet-rich fibrin.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: M-MIST + PRF
Description: modified minimally invasive surgical technique with platelet-rich fibrin alone.
Study: NCT06440070

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Loop Carpal Tunnel Release
Description: Under the guidance of ultrasound, needles are inserted above and below the transverse carpal ligament, respectively, to form a loop around the ligament. Finally, the ligament is cut by pulling the looped thread.
Study: NCT06027827

Intervention type: PROCEDURE
Intervention: Addition of fusion device lateral bone graft
Description: In addition to the central bone graft of the fusion cage, the lateral bone graft of the fusion cage was added.
Study: NCT04687956

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: LYMPHA
Description: Axillary reverse mapping is performed before surgery, axillary lymph node resection is performed, and 'LYMPHA' (Lymphatic microsurgical preventing healing approach) is performed, and the surgery is terminated. Subsequently, the occurrence of lymphedema is followed up.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: control
Description: In the control group, axillary lymph node resection is performed and the surgery is terminated without additional procedures. Subsequently, the occurrence of lymphedema is followed up.
Study: NCT05537233

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Semaglutide up to 1 mg per week in addition to standard closed-loop therapy

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Injection placebo up to 1 mg per week in addition to standard closed-loop therapy
Study: NCT05706948

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (With Face Mask)
Description: High Intensity Interval Training on Treadmill for 4 weeks with Face mask

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (Without Face Mask)
Description: High Intensity Interval Training on Treadmill for 4 weeks with out Face mask
Study: NCT05533996

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: ultrasound
Description: Sonographic examination to measure the maternal pre-peritoneal fat thickness and subcutaneous fat thickness and calculate body fat index
Study: NCT06024070

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rigid Tape
Description: The patient was rested in supine or long sitting position on a table Pre-wrap was applied to cover all the area before tapping Two strips used separately as anchors at the two ends of the pre-wrap. Two Longitudinal stirrup of tape were used from medial side of the superior anchor to lateral side of the same anchor.~Two horizontal stirrup of tape were used from medial side of the distal anchor to lateral side of the same anchor to support the medial side of the foot.~Figure-of-eight straps were utilized for the taping. Lateral heel lock was applied.The tape then proceeded from the lateral side of the foot, looping around the heel, and returning to the same starting point by crossing over the Achilles tendon from behind.~Medial heel lock was applied, the tape application was similar to the lateral heel lock but was at the opposite direction.~Superior and inferior anchors were applied to support all the previous strips
Study: NCT06483724

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cervical tourniquet
Description: After opening the abdominal wall, To reduce bleeding during PAS, make the uterine incision above the placenta's intrauterine borders .~2-investigators extract the uterus from the abdomen 3-An assistant slides a sterile Foley catheter (Ch 16/18 French) down to the lowest point and secures it en bloc around the cervix 4-The bladder peritoneum is isolated from the uterus 5-To remove myometrial tissue, leave a margin of at least 2 cm superior to the cervical internal ostium using electrocautery or scissors .

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: uterine artery ligation
Description: After opening the abdominal wall, To reduce bleeding during PAS, make the uterine incision above the placenta's intrauterine borders .~2-investigators extract the uterus from the abdomen 3-The bladder peritoneum is isolated from the uterus 4-The uterine vessels were ligated in continuity at the level of the utero-vesical fold on each side 5-To remove myometrial tissue, leave a margin of at least 2 cm superior to the cervical internal ostium using electrocautery or scissors .
Study: NCT05030142

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mechanical Thrombectomy
Description: Mechanical thrombectomy (using a stent retriever among the following:Trevo NXT ProVue Retriever, Catchview mini, pReset Lite, Tigertriever 13) in association with the best medical treatment (usual care)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Best medical treatment alone
Description: Best medical treatment alone (usual care)
Study: NCT06301451

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: General dietary guidance and hydrogen water prepared by portable hydrogen rich water machine
Description: The trial group drink the hydrogen water prepared by the experimental equipment on the basis of receiving general dietary guidance.
Study: NCT04936061

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CoolStat active device
Description: The CoolStat active device will administer a therapeutic flow of dry air into the nostril.
Study: NCT05923424

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN17092
Description: Single ascending intravenous (IV) or subcutaneous (SC) administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN17092
Description: Single ascending intravenous (IV) or subcutaneous (SC) administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN17092
Description: Single ascending intravenous (IV) or subcutaneous (SC) administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN17092
Description: Single ascending intravenous (IV) or subcutaneous (SC) administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN17092
Description: Single ascending intravenous (IV) or subcutaneous (SC) administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN17092
Description: Single ascending intravenous (IV) or subcutaneous (SC) administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN17092
Description: Single ascending intravenous (IV) or subcutaneous (SC) administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN17092
Description: Single ascending intravenous (IV) or subcutaneous (SC) administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN17092
Description: Single ascending intravenous (IV) or subcutaneous (SC) administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN17092
Description: Single ascending intravenous (IV) or subcutaneous (SC) administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single ascending IV or SC administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single ascending IV or SC administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single ascending IV or SC administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single ascending IV or SC administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single ascending IV or SC administration per the protocol
Study: NCT04936061

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CoolStat active device
Description: The CoolStat active device will administer a therapeutic flow of dry air into the nostril.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: CoolStat sham device
Description: The CoolStat sham device will administer a sham flow of ambient air into the nostril.
Study: NCT05923424

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single ascending IV or SC administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single ascending IV or SC administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single ascending IV or SC administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single ascending IV or SC administration per the protocol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo
Description: Single ascending IV or SC administration per the protocol
Study: NCT05065125

Intervention type: DEVICE
Intervention: digital single-operator cholangioscopy
Description: 1. Duodenoscope passes through esophagus and stomach to the papilla of Vater~2. SpyScope DS Catheter passes through the duodenoscope and into common bile duct~3. After direct visualization of anastomosis site stricture, guidewire is passed through SpyScope DS Catheter above the stricture site.
Study: NCT04620148

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-242
Description: TAK-242 concentrate solution 80 mg/mL for dilution and infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo concentrate solution
Study: NCT04921319

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: VExUS score
Description: The care team will be informed of the VExUS immediately after the ultrasound is performed and given a suggested target for the following 24 hours as follows:~* VExUS 0: The patient will likely tolerate more fluid if clinically needed.~* VExUS 1: The patient has evidence of mild venous congestion. The investigators recommend targeting a net neutral or negative fluid balance with diuresis.~* VExUS 2-3: The patient has evidence of moderate to severe venous congestion. The investigators recommend targeting a fluid balance of negative 1-2L with diuresis. If the investigator cannot obtain ultrasound images of sufficient quality to calculate VExUS, the care team will be informed that there is no recommendation for that subject on that day.
Study: NCT06217562

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vasopressin
Description: Intravenous vasopressin infusion added to first-line vasopressors. Recommended vasopressin dose is 1.8 units/hour (equivalent to 0.03 units/minute) at a fixed rate.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vasopressin
Description: Intravenous vasopressin infusion added to first-line vasopressors. Recommended vasopressin dose is 1.8 units/hour (equivalent to 0.03 units/minute) at a fixed rate.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Recommendation to use a lower initiation threshold for vasopressin
Description: Recommended to initiate intravenous vasopressin infusion if the combined dose of other vasopressors reaches ≥0.1 mcg/kg/min of norepinephrine (or equivalent)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Recommendation to use a higher initiation threshold for vasopressin
Description: Recommended to initiate intravenous vasopressin infusion if the combined dose of other vasopressors reaches ≥0.4 mcg/kg/min of norepinephrine (or equivalent)
Study: NCT05542212

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magenetic Stimulation
Description: Intermittent Theta Burst Stimulation (iTBS) treatment plan: iTBS treatment for the left dlPFC were used for a total of 20 treatments (one time each Monday to Friday, continuous treatment for 4 weeks).

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Transcranial Magenetic Stimulation
Description: Sham stimulation: The coil angle is set at 90° to the scalp for Sham stimulation of the left dlPFC for a total of 20 treatments (one time each Monday to Friday, continuous treatment for 4 weeks).
Study: NCT04087291

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Chiropractic Care
Description: Chiropractic interventions:~1. Patient education.~2. Passive interventions, such as spinal manipulation and myofascial therapies which include thrust type (high velocity-low amplitude) spinal manipulation for the low back, non-thrust manipulation (joint mobilization), and use of manually held instruments, such as an Activator. Myofascial therapies are also commonly used, such as myofascial release and trigger point therapy.~3. Transitional interventions, such as therapeutic exercise.~4. Recommendations for active interventions, such as general exercise and mind-body therapies.~5. Self-management advice, which refers to advice given to build the capacity of a person to self-monitor, control, and/or reduce the impact of a condition over time.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Chiropractic Care
Description: Chiropractic interventions:~1. Patient education.~2. Passive interventions, such as spinal manipulation and myofascial therapies which include thrust type (high velocity-low amplitude) spinal manipulation for the low back, non-thrust manipulation (joint mobilization), and use of manually held instruments, such as an Activator. Myofascial therapies are also commonly used, such as myofascial release and trigger point therapy.~3. Transitional interventions, such as therapeutic exercise.~4. Recommendations for active interventions, such as general exercise and mind-body therapies.~5. Self-management advice, which refers to advice given to build the capacity of a person to self-monitor, control, and/or reduce the impact of a condition over time.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Chiropractic Care
Description: Chiropractic interventions:~1. Patient education.~2. Passive interventions, such as spinal manipulation and myofascial therapies which include thrust type (high velocity-low amplitude) spinal manipulation for the low back, non-thrust manipulation (joint mobilization), and use of manually held instruments, such as an Activator. Myofascial therapies are also commonly used, such as myofascial release and trigger point therapy.~3. Transitional interventions, such as therapeutic exercise.~4. Recommendations for active interventions, such as general exercise and mind-body therapies.~5. Self-management advice, which refers to advice given to build the capacity of a person to self-monitor, control, and/or reduce the impact of a condition over time.
Study: NCT05552898

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sleep Study Product Usage
Description: Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sleep Study Product Usage
Description: Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sleep Study Product Usage
Description: Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sleep Study Product Usage
Description: Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Sleep Study Product Usage
Description: Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Sleep Study Product Usage
Description: Participants will use their Radicle Sleep study product as directed for a period of 4 weeks.
Study: NCT05383157

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief mindfulness
Description: Training in mindfulness focused on breathing and pain sensations to enhance decentering, meta-awareness, and interoceptive awareness.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Usual pain care as delivered in the clinic involving pain assessment and prescription of analgesics.
Study: NCT04253717

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor control exercise program
Description: Structure physical training aimed at strengthening muscles of the lumbo-pelvic-hip core complex in order to improve stabilization and alignment of the spine and pelvis.
Study: NCT04512911

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endocardial ablation
Description: Endocardial ablation of VT

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endocardial ablation
Description: Endocardial ablation of VT

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endocardial- Epicardial ablation
Description: Epicardial ablation of VT in addition to endocardial ablation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endocardial- Epicardial ablation
Description: Epicardial ablation of VT in addition to endocardial ablation

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antiarrhythmic medications
Description: Addition of anti arrhythmic medication or dose increase